JOHN C. WOLFE, M.D.; WARREN D. JOHNSON Jr., M.D., F.A.C.P.
The in-vitro activity of penicillin and streptomycin against 48 strains of viridans streptococci isolated from patients with endocarditis was studied. All strains were inhibited by penicillin, up to 0.4 μg/ml, and streptomycin, up to 200 μg/ml. The combination of penicillin, 0.8 μg/ml, and streptomycin, 5 μg/ml, sterilized a 106 inoculum of 37 of the 48 strains. Penicillin, 1.6 μg/ml, killed only 1 strain, and none were killed by streptomycin, 10 μg/ml. Rate of killing was also increased for 45 of the 48 strains by the addition of streptomycin to penicillin. Over 100 patients with endocarditis caused by penicillin-sensitive strains of viridans streptococci (minimal inhibitory concentration, ≤ 0.1 μg/ml) have been treated at the New York Hospital with parenteral penicillin and streptomycin for 2 weeks, followed by parenteral penicillin alone for an additional 2 weeks, without relapse. Penicillin, in combination with streptomycin, appears to be the optimal therapy for viridans streptococcal endocarditis.
WOLFE JC, JOHNSON WD. Penicillin-Sensitive Streptococcal Endocarditis: In-Vitro and Clinical Observations on Penicillin-Streptomycin Therapy. Ann Intern Med. ;81:178–181. doi: 10.7326/0003-4819-81-2-178
Download citation file:
Published: Ann Intern Med. 1974;81(2):178-181.
Cardiology, Endocarditis, Infectious Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use